申请人:Schering A.G.
公开号:US04920116A1
公开(公告)日:1990-04-24
N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4-(methylsylfonylamino)benzamides of the formula ##STR1## wherein R is C.sub.1 -C.sub.4 straight chain alkyl, one of R.sub.1, R.sub.2 and R.sub.3 is a phenyl or naphthyl group and the others are hydrogen, --NR.sub.4 R.sub.5 is a secondary or teritary amino group, X and X.sub.1 are hydrogen or alkyl and n is 0 or 1, are useful as antiarrhythmic agents in the treatment of cardiac arrhythmias especially as combination Class I/Class III agents.
公式为##STR1##的N-(氨基烷基)-取代(N或C烷基)-芳基-4-(甲基磺酰氨基)苯甲酰胺,其中R为C.sub.1-C.sub.4直链烷基,R.sub.1、R.sub.2和R.sub.3中的一个为苯基或萘基,其余为氢,--NR.sub.4 R.sub.5为二级或三级氨基基团,X和X.sub.1为氢或烷基,n为0或1,可用于治疗心律失常,特别是作为I类/III类联合药物。